Communication in ICU During COVID-19

Sponsor
NMC Specialty Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04602351
Collaborator
(none)
296
1
1.3
225.2

Study Details

Study Description

Brief Summary

This study explores the actual situation of communication during the Coronavirus disease 2019 (COVID-19) pandemic in the South Asia and Middle East region. The purpose is to assess the effect of the limited visitor policy during the COVID-19 pandemic, on the pattern of interaction of critically ill patients to their kin/ guardian and doctor-family members communication.

Primary objective of this study are as follows:
  1. Explore the changes in communication pattern with limited contact during the COVID-19 pandemic.

  2. Assess the methods of informed consent in Intensive care units (ICUs) during the same period

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Communication

Detailed Description

An observational, cross-sectional, web-based questionnaire survey, with multi-centre involvement across hospitals in the South Asia and middle-east region. The questionnaire consists of two sections. Section one obtains information from participants regarding communication and visiting practices in ICU during pre-COVID-19 era, and the Section two obtains information regarding the policy changes if any during the COVID-19 pandemic in regards to safety of healthcare workers (HCWs) and public.

In order to obtain the largest representation of South Asia and Middle East ICUs, a network of research doctors as facilitators from each country is created. The role of the facilitators is to contact and recruit adult ICUs within their country. Each facilitator contacts the hospitals (public and private), creating a network of collaborating doctors/nurses (participants) from those hospitals who expressed their willingness to participate.

Data collection: a web based Google Forms with online access will be used Only one entry per ICU will be collected during the study. Statistic analysis: a descriptive analysis is planned for the general characteristics of the participating units and the study population.

Study Design

Study Type:
Observational
Actual Enrollment :
296 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Communication in ICU During COVID-19: Multinational, Multicentric Cross-sectional Survey (ComICU)
Actual Study Start Date :
Mar 22, 2021
Actual Primary Completion Date :
Apr 7, 2021
Actual Study Completion Date :
May 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Changes in the pattern of family members visiting process [12 months]

    Using a questionnaire the changes in visiting policy for family members or friends will be recorded from last year (before COVID-19 pandemic). This will include, visiting policy, visiting hours and their change after pandemic at the time of study (November 2020).

  2. Changes in process of communication between health care workers(HCWs) and family members [12 months]

    Through a questionnaire, the process of communication between HCWs and family members or friends before pandemic (November 2019) and November 2020 will be recorded. This will include the responsible HCW for communication, place of communication and method of communication (in person versus electronic)

Secondary Outcome Measures

  1. Changes in process of informed consent in ICU [12 months]

    Through a questionnaire, the process of informed consent for procedures and end of life (EOL) or do not attempt to resuscitation (DNAR) in ICU will be collected and its change in last 12 months (from November 2019 to November 2020)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Adult ICUs,

  2. New created COVID-19 ICUs during the pandemic

Exclusion Criteria:
  1. Paediatric ICU

  2. Neonatal ICU

Contacts and Locations

Locations

Site City State Country Postal Code
1 NMC Specialty Hospital Dubai United Arab Emirates 7832

Sponsors and Collaborators

  • NMC Specialty Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Prashant Nasa, Head Critical Care Medicine, NMC Specialty Hospital
ClinicalTrials.gov Identifier:
NCT04602351
Other Study ID Numbers:
  • ComICU
First Posted:
Oct 26, 2020
Last Update Posted:
May 11, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prashant Nasa, Head Critical Care Medicine, NMC Specialty Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2021